Nuvation Bio (NUVB) News Today $2.92 -0.04 (-1.19%) Closing price 03:59 PM EasternExtended Trading$2.99 +0.08 (+2.57%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUVB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Nuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Buy" from AnalystsAugust 28 at 5:21 AM | marketbeat.comNuvation Bio to Participate in Upcoming Investor ConferencesAugust 27 at 4:05 PM | businesswire.comH.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB)August 26 at 2:19 AM | msn.comNuvation Bio Inc. $NUVB Shares Acquired by Algert Global LLCAugust 24, 2025 | marketbeat.comWall Street Zen Upgrades Nuvation Bio (NYSE:NUVB) to HoldAugust 18, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 9.7% Higher - Still a Buy?August 15, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Announces Quarterly Earnings ResultsAugust 11, 2025 | marketbeat.comRoyal Bank Of Canada Increases Nuvation Bio (NYSE:NUVB) Price Target to $7.00August 10, 2025 | marketbeat.comWedbush Reaffirms Their Buy Rating on Nuvation Bio (NUVB)August 10, 2025 | theglobeandmail.comNuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual CongressesAugust 10, 2025 | theglobeandmail.comWall Street Zen Downgrades Nuvation Bio (NYSE:NUVB) to SellAugust 10, 2025 | marketbeat.comH.C. Wainwright Sticks to Their Buy Rating for Nuvation Bio (NUVB)August 9, 2025 | theglobeandmail.comNuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 7, 2025 | gurufocus.comNuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 7, 2025 | businesswire.comNuvation Bio Inc. (NYSE:NUVB) Given Average Rating of "Buy" by BrokeragesAugust 2, 2025 | marketbeat.comNuvation Bio (NUVB)’s Taletrectinib Selected as Preferred Agent for Cancer TreatmentAugust 1, 2025 | finance.yahoo.comGSA Capital Partners LLP Has $1.16 Million Stock Position in Nuvation Bio Inc. (NYSE:NUVB)August 1, 2025 | marketbeat.comRBC Capital Maintains a Buy on Nuvation Bio (NUVB) With a $6 PTAugust 1, 2025 | msn.comInstitutional investors may adopt severe steps after Nuvation Bio Inc.'s (NYSE:NUVB) latest 5.9% drop adds to a year lossesJuly 31, 2025 | finance.yahoo.comNuvation Bio (NUVB) Expected to Announce Earnings on ThursdayJuly 31, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 8.6% Higher - Should You Buy?July 29, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Upgraded at Wall Street ZenJuly 26, 2025 | marketbeat.comNuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025July 24, 2025 | businesswire.comNuvation Bio (NYSE:NUVB) Trading Up 5.4% - What's Next?July 16, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Down 5.2% - Should You Sell?July 14, 2025 | marketbeat.comAll You Need to Know About Nuvation Bio (NUVB) Rating Upgrade ... - NasdaqJuly 11, 2025 | nasdaq.comNuvation Bio (NYSE:NUVB) Shares Gap Up - What's Next?July 9, 2025 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 7, 2025 | marketbeat.comNuvation Bio Inc. (NUVB) latest stock news and headlines - Yahoo FinanceJuly 2, 2025 | uk.finance.yahoo.comNuvation Bio (NYSE:NUVB) Stock Price Up 8% - Time to Buy?June 30, 2025 | marketbeat.comJMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch PlansJune 29, 2025 | msn.comNuvation Bio (NYSE:NUVB) Sees Strong Trading Volume - Here's What HappenedJune 25, 2025 | marketbeat.comNuvation Bio's (NUVB) "Market Outperform" Rating Reaffirmed at JMP SecuritiesJune 25, 2025 | marketbeat.comRBC Capital Lowers PT on Nuvation Bio (NUVB) to $6 But Keeps a Buy RatingJune 24, 2025 | msn.comNuvation Bio jumps after insiders purchase shares worth over $1.1MJune 20, 2025 | msn.comNuvation Bio (NYSE:NUVB) Shares Gap Up - Here's WhyJune 20, 2025 | marketbeat.comFounder of Nuvation Bio David Hung Buys More StockJune 20, 2025 | finance.yahoo.comNuvation Bio price target lowered to $6 from $10 at RBC CapitalJune 18, 2025 | investing.comNuvation Bio: A Justified Fall Based On Post-Marketing RequirementsJune 18, 2025 | seekingalpha.comRoyal Bank of Canada Has Lowered Expectations for Nuvation Bio (NYSE:NUVB) Stock PriceJune 17, 2025 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Down - Time to Sell?June 16, 2025 | marketbeat.comOnco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI™ (taletrectinib), Manufactured by Nuvation Bio Inc.June 16, 2025 | globenewswire.comNuvation Bio price target maintained at $6 by Citizens JMPJune 14, 2025 | investing.comNuvation Bio’s SWOT analysis: FDA approval boosts stock prospectsJune 14, 2025 | investing.comNuvation Bio (NYSE:NUVB) Downgraded to "Sell" Rating by Wall Street ZenJune 14, 2025 | marketbeat.comNuvation Bio Stock Short Interest Report | NYSE:NUVB | BenzingaJune 13, 2025 | benzinga.comUS FDA approves Nuvation Bio's rare lung cancer drugJune 13, 2025 | msn.comNuvation Bio (NYSE:NUVB) Trading Down 5.5% - Here's What HappenedJune 12, 2025 | marketbeat.comU.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung CancerJune 11, 2025 | sg.finance.yahoo.comNuvation Bio granted FDA approval for lung cancer therapy IbtroziJune 11, 2025 | msn.com Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NUVB Media Mentions By Week NUVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.820.99▲Average Medical News Sentiment NUVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼44▲NUVB Articles Average Week Get the Latest News and Ratings for NUVB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nuvation Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Lantheus News Arcellx News Akero Therapeutics News Zai Lab News Mirum Pharmaceuticals News MoonLake Immunotherapeutics News Protagonist Therapeutics News Apellis Pharmaceuticals News Jyong Biotech News Metsera News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvation Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access